💨 Abstract
Oramed Pharmaceuticals reported a net income of $13.3 million for the second quarter. The company, based in New York, earned 31 cents per share. However, excluding non-recurring gains, the adjusted losses were 5 cents per share.
Courtesy: WTOP Staff
Suggested
‘These are human beings’: Religious leaders criticize President Trump’s grim portrayal of DC -
Drive Shack: Q2 Earnings Snapshot -
Carbon Streaming: Q2 Earnings Snapshot -
Barbadillo, la prisión sin barrotes para expresidentes que se ha convertido en símbolo de la crisis política en Perú -
Ziopharm: Q2 Earnings Snapshot -
How Rattler and Shough handled live pass rush will be another data point in Saints’ QB competition -
Md. gov. calls Trump a ‘chicken hawk’ in use of National Guard, while Va. gov. says it will make DC safer -
Woman pleads guilty to assault for spitting on top DC prosecutor during interview -
Is the extra law enforcement presence in DC working? -